Salute e Benessere

Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives…

Bagsværd, Denmark, 14 August 2024— This company announcement discloses the data of the transaction(s) made in Novo Nordisk shares by the company's board members, executives and their associated persons in accordance with Article 19 of Regulation No. 596/2014 on market abuse.The company's board members, executives and their associated persons have reported the transactions to Novo Nordisk and have given Novo Nordisk power of attorney on their behalf to publish trading in Novo Nordisk...
Nasdaq GlobeNewswire
14/08/2024

Anand Patel new Chief Financial Officer of Medicover

"I warmly welcome Anand to Medicover. Anand's professional experience will be important as we continue to execute our strategy and growth journey," says Fredrik Rågmark, CEO. "I warmly welcome Anand to Medicover. Anand's professional experience will be important as we continue to execute our strategy and growth journey," says Fredrik Rågmark, CEO. Anand Patelwill replaceJoe Ryan, who has served as CFO of Medicover for over 28 years and will be retiring, as announced last…
PR Newswire
14/08/2024

Tiziana Life Sciences Regains Compliance with Nasdaq Listing Minimum Bid Price…

Tiziana was previously notified by Nasdaq on July 19, 2023 that it was not in compliance with the minimum bid-price listing rule (under Rule 5550(a)(2)) because its common stock failed to meet the closing bid price of $1.00 or more for 30 consecutive business days. To regain compliance, the Company was required to maintain a minimum closing bid price of $1.00 or more for at least ten consecutive trading days which was met on August 9, 2024. Consequently, a scheduled hearing before the...
Nasdaq GlobeNewswire
14/08/2024

NICE recommends ORGOVYX® (relugolix) as the first oral ADT treatment for hormone…

Prostate cancer is the most common cancer in men across the UK with 44,000 new cases diagnosed in England each year and almost ten times as many men living with the condition.2 Since the early 1990s diagnostic techniques have advanced and prostate cancer incidence rates have increased by more than half (53%) in males in the UK (2017-2019).3 Prostate cancer is the most common cancer in men across the UK with 44,000 new cases diagnosed inEnglandeach year and almost ten times as many men...
PR Newswire
14/08/2024

Dr. Yogesh Shouche is appointed as Director of SKAN

Dr. Yogesh Shouche, Director, SKAN, said "I am honoured to accept the responsibility given by SKAN and the faith reposed in me. I value this opportunity and would work towards making SKAN a world-class place for deep science with a strong focus on societal needs. With the SKAN team I will work to build and nurture new talent and capabilities in the organization to change millions of lives through our research." Dr. Yogesh Shouche, Director, SKAN, said" I am honoured to accept…
PR Newswire
14/08/2024

Residential Robotic Vacuum Cleaner Market to Reach $9.6 Billion, Globally, by…

Request The Sample PDF Of This Report: https://www.alliedmarketresearch.com/request-sample/A06509 Request The Sample PDF Of This Report:https://www.alliedmarketresearch.com/request-sample/A06509 Prime determinants of growth The global residential robotic vacuum cleaner market has experienced growth due to several factors such as increase in adoption of smart home technologies, advancements in AI & machine learning, and heightened awareness of hygiene. However, high...
PR Newswire
14/08/2024

Draghici Dental Gains Market Edge with Chamlion's Dental Metal 3D Printing…

A New Era of Digital Transformation A New Era of Digital Transformation With over 15 years of experience and a network of more than 500 collaborators acrossEurope, Draghici Dental has built a reputation for delivering top-notch dental solutions. And, they are dedicated to advancing dental technology and maintaining high international standards. However, despite their extensive expertise and success, Draghici Dental faced a significant challenge: their production capacity was...
PR Newswire
14/08/2024

Intracranial Pressure (ICP) Monitoring Market to Reach $0.6 Billion, Globally…

Request Sample of the Report on Intracranial Pressure (ICP) Monitoring Market Forecast 2033 - https://www.alliedmarketresearch.com/request-sample/A149770 Request Sample of the Report on Intracranial Pressure (ICP) Monitoring Market Forecast 2033 -https://www.alliedmarketresearch.com/request-sample/A149770 Prime determinants of growth Rise in prevalence of traumatic brain injuries (TBIs), rise in demand for minimally invasive procedures and increase in geriatric population are...
PR Newswire
14/08/2024

SANY Heavy Industry Pioneers Global Construction Machinery Innovations…

SY870E and SY1650E Large Excavator Series SY870E and SY1650E Large Excavator Series The SY870E boasts a 6,000V high-voltage electric drive system coupled with a 370kW electric motor, offering more than 30% savings in operational expenses compared to traditional diesel-powered models. The SY1650E is celebrated for its pioneering electrification and digital technologies. The excavator has achieved breakthroughs in 18 core technologies, bridging the gap in 6kV high-voltage technology for...
PR Newswire
14/08/2024

Genotyping Market to Reach $61.6 Billion, Globally, by 2033 at 13.8% CAGR…

Request Sample of the Report on Genotyping Market Forecast 2033 - https://www.alliedmarketresearch.com/request-sample/840 Request Sample of the Report on Genotyping Market Forecast 2033 -https://www.alliedmarketresearch.com/request-sample/840 Prime determinants of growth The increasing prevalence of genetic disorders worldwide, such as cancer, cardiovascular diseases, and neurological disorders, shift towards personalized medicine, and increasing demand for forensic DNA analysis are...
PR Newswire
14/08/2024

SOPHiA DDM™ Platform Certified Under IVDR

The transition from the In Vitro Diagnostic Directive (IVDD) to the IVDR in the European Union marks an important advancement in regulatory standards for genetic testing and analysis, including software used for analysis. The new standards promote transparency and traceability throughout genomic analysis processes, helping to ensure the reliability and accuracy of diagnostic results and ultimately patient safety. Users can save time and costs by leveraging an IVDR compliant software platform…
PR Newswire
14/08/2024

ELFBAR actions against counterfeits in South Africa

Raid operations Raid operations The raid operation in July, conducted under a search warrant, was in tandem inJohannesburgandCape Town. The seized counterfeits consist of many of the outdated models, such as CR5000, BC5000, and EB1500. More criminal charge filings are on the way. According to the Police Service, offenders will be typically fined, and in cases of severe offenses, imprisonment may be imposed. Warnings sent In both cities, ELFBAR issued warning letters to...
PR Newswire
14/08/2024

44,767 Orion Corporation A shares converted into B shares

ORION CORPORATIONSTOCK EXCHANGE RELEASE – OTHER INFORMATION DISCLOSED ACCORDING TO THE RULES OF THE EXCHANGE 14 AUGUST 2024 at 9.30 EEST 44,767 Orion Corporation A shares converted into B shares In accordance with Section 3 of the Articles of Association of Orion Corporation, 44,767 A shares have been converted into 44,767 B shares. The conversion has been entered into the Trade Register on 14 August 2024.The total number of shares in Orion Corporation is 141,134,278...
Nasdaq GlobeNewswire
14/08/2024

SKF makes strategic acquisition to strengthen its lubrication management…

JSG had sales of approximately SEK 550 million in their latest fiscal year, is margin accretive and has 86 employees. Following the acquisition, net sales for SKF's Lubrication Management business will be around SEK 7 billion. JSG had sales of approximatelySEK 550 millionin their latest fiscal year, is margin accretive and has 86 employees. Following the acquisition, net sales for SKF's Lubrication Management business will be aroundSEK 7 billion. "This acquisition is a good strategic...
PR Newswire
14/08/2024

Medsenic receives the intention to grant a key European patent from EPO…

INSIDE INFORMATIONMedsenic's experimental drug, arsenic trioxide, can now be investigated for the treatment of multiple sclerosis through repeated cycles of administration by multiple routes, including intravenous, oral and other innovating routes of administration.Mont-Saint-Guibert, Belgium, August 14, 2024, 7.00am CET –BioSenic(Euronext Brussels and Paris: BIOS), the clinical-stage company specializing in serious autoimmune and inflammatory diseases, today announces that...
Nasdaq GlobeNewswire
14/08/2024

TUMI UNVEILS FALL 2024 VOYAGEUR LEATHER AND 19 DEGREE FRAME COLLECTIONS WITH…

In this dynamic campaign, TUMI reintroduces a luxurious, fashion-forward spin on its iconic Voyageur collection made with high-quality rich leather. Each piece is meticulously crafted with functionality and style in mind—including the new TUMI "T" logo hardware—balancing the brand's signature elevation and innovation with timeless, minimalist allure. The Voyageur Leather collection features backpacks, totes, shoulder bags and crossbodies. Brand-new to the collection is the Mini Train…
PR Newswire
14/08/2024

Leqembi approved for the treatment of Alzheimer's disease in the United Arab…

Leqembi selectively binds to soluble amyloid-beta (Aβ) aggregates (protofibrils[4]), as well as insoluble Aβ aggregates (fibrils) which are a major component of Aβ plaques in AD, thereby reducing both Aβ protofibrils and Aβ plaques in the brain. Leqembi is the first approved treatment shown to reduce the rate of disease progression and to slow cognitive and functional decline through this mechanism. Leqembi is also approved in the U.S., Japan, China, South Korea, Hong Kong, and Israel, and is…
PR Newswire
14/08/2024

Bavarian Nordic Receives Order from HERA and Announces Significant Donation of…

HERA will procure 175,420 doses for immediate response to the concerning mpox outbreak in Africa, and furthermore, Bavarian Nordic will donate 40,000 doses to HERA, also to be distributed to the Africa CDC.COPENHAGEN, Denmark, August 13, 2024– Bavarian Nordic A/S (OMX: BAVA) announced today a new order from HERA (the European Health Emergency Preparedness and Response Authority) for the Company's MVA-BN ®vaccine, the only FDA and EMA-approved mpox vaccine. HERA will procure 175,420...
Nasdaq GlobeNewswire
13/08/2024

Transactions with shares and linked securities in Genmab A/S made by managerial…

Company Announcement COPENHAGEN, Denmark; August 13, 2024 –Genmab A/S(Nasdaq: GMAB) - In accordance with Article 19 of Regulation No. 596/2014 on Market Abuse and Implementing Regulation 2016/523, this document discloses the data of the transactions made in Genmab A/S (Nasdaq: GMAB) by managerial employees and their closely associated persons.The company's managerial employees and their closely associated persons have given Genmab A/S power of attorney on their behalf to...
Nasdaq GlobeNewswire
13/08/2024

Capital Increase in Genmab as a Result of Employee Warrant Exercise

Company Announcement COPENHAGEN, Denmark; August 13, 2024 –Genmab A/S(Nasdaq: GMAB) will increase its share capital by 28,193 shares as a consequence of the exercise of employee warrants. The increase is effected without any preemption rights for the existing shareholders of the company or others. The shares are subscribed in cash at the following price per share of nominally DKK 1:107 shares at DKK 962.00, 27,188 shares at DKK 1,032.00, 279 shares at DKK 1,050.00, 125 shares at...
Nasdaq GlobeNewswire
13/08/2024

Bavarian Nordic Announces FDA Acceptance and Priority Review of the BLA for its…

PDUFA target action date of February 14, 2025COPENHAGEN, Denmark, August 13, 2024– Bavarian Nordic A/S (OMX: BAVA) today announced that the U.S. Food and Drug Administration (FDA) has accepted and granted Priority Review for the Biologics License Application (BLA) for CHIKV VLP, the Company's vaccine candidate for immunization to prevent disease caused by chikungunya virus infection in individuals 12 years of age and older.The Priority Review designation means the FDA is targeting...
Nasdaq GlobeNewswire
13/08/2024

Medical Smart Textile Market Size to Grow USD 3273.6 Million by 2030 at a CAGR…

Get Free Sample @ https://reports.valuates.com/request/sample/QYRE-Auto-3Z9383/Global_Medical_Smart_Textile_Market Get Free Sample @ https://reports.valuates.com/request/sample/QYRE-Auto-3Z9383/Global_Medical_Smart_Textile_Market Major Factors Driving the Growth of Medical Smart Textile Market: Because more sophisticated textile technologies are being incorporated into healthcare applications, the market for medical smart textiles is expanding significantly. In order to monitor,...
PR Newswire
13/08/2024

IPSEN - Buy-back programme - Art 5 of MAR - Week 32 - 2024

AggregatedpresentationbydayandbymarketPurchases of own shares from August 5th to August 7th, 2024 Name of the IssuerIdentity code of the IssuerDay of the transactionIdentity code of the financial instrumentTotal daily volume (in number of shares)Daily weighted average purchase price of the sharesMarket (MIC Code) IPSEN549300M6SGDPB4Z94P1105/08/2024FR00102591509 021103,0295XPARIPSEN549300M6SGDPB4Z94P11...
Nasdaq GlobeNewswire
13/08/2024

Medsenic/BioSenic patent granted in Japan for more protection of its therapeutic…

PRIVILEGED INFORMATIONComposition-of-matter patent covers the therapeutic use of arsenic salts and metal ions through various routes of administration.Enriched IP portfolio protects arsenic trioxide (ATO) use combined with copper ions delivery, which has demonstrated increased therapeutic potential for indications ranging from immune to cancer and infectious diseases. Mont-Saint-Guibert, Belgium, 13 août 2024, 6.00pm CET –BioSenic(Euronext Brussels and Paris: BIOS), the...
Nasdaq GlobeNewswire
13/08/2024
Altri  Comunicati